Results 201 to 210 of about 1,697,934 (260)

Long-term Safety and Effectiveness of Rezafungin Treatment in Candidemia and Invasive Candidiasis: Results From an Early Access Program in Italy and Germany. [PDF]

Open Forum Infect Dis
Trapani F, Viceconte G, Morena V, Tiseo G, Mori G, Kölking B, Khatamzas E.   +6 more
europepmc   +1 more source

Invasive Candidiasis in Surgery

Alessandra Oliva, Mario Venditti
openaire   +1 more source

Invasive Candidiasis [PDF]

Seminars in Respiratory and Critical Care Medicine, 2020
Invasive candidiasis (IC) is the most frequent health care associated invasive fungal infection. It is also associated with high morbidity, mortality, and cost.
M. González-Lara, L. Ostrosky-Zeichner
semanticscholar   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Candidemia and Invasive Candidiasis.

Infectious Disease Clinics of North America, 2021
Invasive candidiasis (IC) is a collective term that refers to a group of infectious syndromes caused by a variety of species of Candida, 6 of which cause most cases globally. Candidemia is probably the most commonly recognized syndrome associated with IC;
T. Mccarty, C. White, P. Pappas
semanticscholar   +3 more sources

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action

Expert Opinion on Investigational Drugs, 2022
Introduction The epidemiology of invasive Candida infections is evolving. Infections caused by non-albicans Candida spp. are increasing; however, the antifungal pipeline is more promising than ever and is enriched with repurposed drugs and agents that ...
M. Hoenigl, R. Sprute, A. Arastehfar, J. Perfect, C. Lass‐Flörl, R. Bellmann, J. Prattes, G. Thompson, N. Wiederhold, Mohanad M Al Obaidi, B. Willinger, M. Arendrup, P. Koehler, M. Oliverio, M. Egger, Ilan S. Schwartz, O. Cornely, P. Pappas, R. Krause   +18 more
semanticscholar   +1 more source

Rezafungin: a novel antifungal for the treatment of invasive candidiasis.

Future Microbiology, 2021
Rezafungin is a novel echinocandin with exceptional stability and solubility and a uniquely long half-life allowing for front-loaded drug exposure with once-weekly dosing. Rezafungin has been shown comparable to other echinocandins, with activity against
Young Yoon Ham, James S. Lewis, G. Thompson   +2 more
semanticscholar   +1 more source